Jackson Creek Investment Advisors »

Theravance Biopharma shares owned by Jackson Creek Investment Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Jackson Creek Investment Advisors from 13F filings

Historical chart of Jackson Creek Investment Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Jackson Creek Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Jackson Creek Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 119k 16.23

More positions owned by Jackson Creek Investment Advisors

Technipfmc (FTI)
Argan (AGX)
Jabil Circuit (JBL)
Cirrus Logic (CRUS)
California Res Corp (CRC)
Amkor Technology (AMKR)
Patterson-UTI Energy (PTEN)
Dht Holdings (DHT)
Huntington Ingalls Inds (HII)
Mednax (MD)
Myr (MYRG)
MasTec (MTZ)
Northern Oil And Gas Inc Mn (NOG)
Virtu Financial Inc Class A (VIRT)
Nextracker (NXT)

View all positions for Jackson Creek Investment Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
UBS Group

View all funds holding Theravance Biopharma